TransCode Therapeutics Reports Second Quarter 2023 Results; Provides Business Update

Go back to TransCode Therapeutics Reports Second Quarter 2023 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 1.77 +0.01 (0.57%)
Previous Close $1.76    52 Week High
Open $1.87    52 Week Low
Day High $1.91    P/E N/A 
Day Low $1.71    EPS
Volume 59,487